PDB Short entry for 2LD2 HEADER LIPID BINDING PROTEIN 13-MAY-11 2LD2 TITLE SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF HUNTINGTIN (HTT17) IN TITLE 2 PRESENCE OF DPC MICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUNTINGTIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL RESIDUES 1-17; COMPND 5 SYNONYM: HUNTINGTON DISEASE PROTEIN, HD PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: C-TERMINALLY AMIDATED PEPTIDE KEYWDS ALPHA HELIX, LIPID BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.MICHALEK,E.S.SALNIKOV,S.WERTEN,B.BECHINGER REVDAT 3 14-JUN-23 2LD2 1 REMARK SEQADV LINK REVDAT 2 21-AUG-13 2LD2 1 JRNL REVDAT 1 16-MAY-12 2LD2 0 JRNL AUTH M.MICHALEK,E.S.SALNIKOV,B.BECHINGER JRNL TITL STRUCTURE AND TOPOLOGY OF THE HUNTINGTIN 1-17 MEMBRANE JRNL TITL 2 ANCHOR BY A COMBINED SOLUTION AND SOLID-STATE NMR APPROACH. JRNL REF BIOPHYS.J. V. 105 699 2013 JRNL REFN ISSN 0006-3495 JRNL PMID 23931318 JRNL DOI 10.1016/J.BPJ.2013.06.030 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH, X-PLOR NIH, X-PLOR NIH, X-PLOR NIH, X REMARK 3 -PLOR NIH, X-PLOR NIH REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (X-PLOR NIH), DELAGLIO, GRZESIEK, VUISTER, ZHU, REMARK 3 PFEIFER AND BAX (X-PLOR NIH), JOHNSON, ONE MOON REMARK 3 SCIENTIFIC (X-PLOR NIH), SCHWIETERS, KUSZEWSKI, REMARK 3 TJANDRA AND CLORE (X-PLOR NIH), BHATTACHARYA AND REMARK 3 MONTELIONE (X-PLOR NIH), KORADI, BILLETER AND REMARK 3 WUTHRICH (X-PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LD2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000102248. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0.025 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.2-0.3 MM 15N LABELED AT PHE11 REMARK 210 HTT17, 10 % D2O, 25 MM SODIUM REMARK 210 PHOSPHATE, 100 MM D38 DPC, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR NIH REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: TOCSY: 40 MS AND 80 MS NOESY: 150 MS AND 200 MS REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE A 11 H LYS A 15 1.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 13 LYS A 15 N - CA - CB ANGL. DEV. = -11.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 3 -60.87 -92.98 REMARK 500 3 LEU A 4 -75.82 -146.47 REMARK 500 4 ALA A 2 42.28 -144.96 REMARK 500 4 GLU A 5 -36.30 -38.21 REMARK 500 4 SER A 16 -71.76 -47.32 REMARK 500 6 ALA A 2 48.82 -148.26 REMARK 500 6 THR A 3 -77.41 -87.14 REMARK 500 6 LEU A 4 -80.18 -144.64 REMARK 500 6 GLU A 5 -52.12 -159.06 REMARK 500 7 SER A 16 -74.58 -64.41 REMARK 500 8 LEU A 4 -108.20 -107.59 REMARK 500 8 GLU A 5 -59.81 -148.03 REMARK 500 9 THR A 3 -70.69 -90.75 REMARK 500 9 LEU A 4 53.02 37.57 REMARK 500 9 SER A 16 -74.56 -61.92 REMARK 500 10 THR A 3 -66.56 -154.48 REMARK 500 11 THR A 3 -71.41 -139.48 REMARK 500 14 THR A 3 -75.83 -108.36 REMARK 500 14 GLU A 5 -37.97 -39.27 REMARK 500 15 ALA A 2 87.26 -166.22 REMARK 500 15 THR A 3 -69.85 -120.92 REMARK 500 16 GLU A 5 -47.79 62.97 REMARK 500 16 LYS A 6 -48.98 -25.05 REMARK 500 16 SER A 16 -71.27 -59.56 REMARK 500 17 LEU A 4 48.03 -81.76 REMARK 500 18 SER A 16 -71.57 -37.31 REMARK 500 19 ALA A 2 -160.65 55.94 REMARK 500 19 THR A 3 -95.95 -93.35 REMARK 500 19 LEU A 4 -58.50 -142.61 REMARK 500 20 LEU A 4 63.02 -101.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17644 RELATED DB: BMRB REMARK 900 RELATED ID: 2LD0 RELATED DB: PDB DBREF 2LD2 A 1 17 UNP P42858 HD_HUMAN 1 17 SEQADV 2LD2 NH2 A 18 UNP P42858 AMIDATION SEQRES 1 A 18 MET ALA THR LEU GLU LYS LEU MET LYS ALA PHE GLU SER SEQRES 2 A 18 LEU LYS SER PHE NH2 HET NH2 A 18 3 HETNAM NH2 AMINO GROUP FORMUL 1 NH2 H2 N HELIX 1 1 LYS A 6 PHE A 17 1 12 LINK C PHE A 17 N NH2 A 18 1555 1555 1.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000